注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户？ 登录
📅 财富指南：本周财经重头戏，不容错过！
查看财经日历
209.970
+1.150
+0.55%
14/02 - 延迟数据. EUR 货币
- 晨星评级:
- 总资产: 259.36M
Allianz Biotechnologie A EUR
209.970
+1.150
+0.55%
0P00000CML概述
本页面提供Allianz Biotechnologie A EUR的详细介绍，帮助您了解0P00000CML的高管、总资产、投资策略和联系方式等信息。
联络信息
地址
L-2633 Senningerberg
Frankfurt am Main, 60323
Germany
Frankfurt am Main, 60323
Germany
电话
+49 (0) 69 2443-1140
传真
Milano
高管
| 名称 | 标题 | 任期 | 至 |
|---|---|---|---|
| Christopher Chin | - | 2018 | now |
| Peter Pirsch | Senior Portfolio Manager | 2019 | 2023 |
| 背景介紹 | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| Kimberlee W. Millar | Vice President | 2018 | 2021 |
| 背景介紹 | Ms. Millar is a portfolio manager, analyst and director with Allianz Global Investors, which she joined in 2005. As a generalist for the Disciplined Equities group, her primary responsibility is conducting company research; she also helps improve the group’s overall investment processes and contributes toward its portfolio-management efforts. Ms. Millar has 23 years of investment industry experience. She previously worked as an assistant economist at the Investment Company Institute in Washington, D.C., producing mutual-fund-industry research for investment-management firms’ research and marketing departments. Before that, Ms. Millar worked at Heiden Associates Inc., an economic consulting firm in Washington, D.C. She has a B.A. in economics from the University of Calgary, Canada, and an M.A. in economics from Queen’s University, Canada. Ms. Millar is a CFA charterholder and a member of the CFA Institute. | ||
| Hugo Ong | - | 2018 | 2021 |
| Peter Pirsch | Senior Portfolio Manager | 2018 | 2019 |
| 背景介紹 | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| John R. Schroer | Portfolio Manager | 2014 | 2018 |
| 背景介紹 | Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. He is the sector head of the Health Care team. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. in history and international relations and an M.B.A. in finance from the University of Wisconsin. | ||
| Paul A. Wagner | Senior Research Analyst | 2012 | 2014 |
| 背景介紹 | Mr. Wagner, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 2006. He has biotechnology responsibilities for the US Health Care team and has 14 years of investment-industry experience. Mr. Wagner previously worked at PDL BioPharma in corporate and business development, and was a vice president and senior equity-research analyst in the biotechnology sector at Lehman Brothers. He has a B.S. in chemistry from the University of Wisconsin and a Ph.D. in chemistry from the California Institute of Technology. | ||
| Nicole Papassavvas | - | 2008 | 2012 |
| Javier Latorre | - | 2007 | 2012 |
在评论中添加图表
确认屏蔽
确定屏蔽%USER_NAME%？
如果屏蔽，您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人，因此必须等待48小时才能重新屏蔽。
举报该评论
您举报该评论的原因为：
该评论已被标注
谢谢您!
您的举报将会被发送到管理员进行审核